The timing of the news was pretty poor, since parents are not particularly keen on more drugs for children right now, with all the mandates trying to force experimental vaccines on kids.
Not that much happened with the ticker today since FDA approvals and patents don't always translate into sales. They may have a product, but unless they demonstrate a market (and millions of $ in orders for it), for it that isn't already covered, the news won't do much, as shown. EYES had a treatment for blindness, and it's now 1.80/share, after up into the $20's on it's original pump on news. This one fell pretty flat. Timing is everything.
Happy trading!
News 
Market Data 
Discover 
